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Introduction 
 
Delirium was defined by the American Psy-
chiatric Association as a  mental disorder 
characterized by an abnormal state of cogni-
tion and awareness (American Psychiatric 
Association, 1987). Additional delirium fea-
tures include disorientation, inattention, mis-
perception and hallucinations (American Psy-
chiatric Association, 1987). Delirium sub-
types (hypoactive, hyperactive and mixed) 
were identified in 1983, by Lipowski 
(Lipowski, 1983). The hypoactive subtype is 
frequently called “pure lethargy” or “quiet de-
lirium.” See Table 1. It manifests itself as de-
creased psychomotor activity, lethargy, inat-
tention, slow responses to questions, and 
looks similar to depression and sedation (Bui, 
Pham, Shirkey, & Swan, 2017; Bush et al., 
2017; Han et al., 2009; Wan, Kasliwal, 
McKenzie, & Barrett, 2011). As a result, it is 
often overlooked without a standardized de-
lirium assessment (Han et al., 2009; Robin-
son, Raeburn, Tran, Brenner, & Moss, 2011; 
Zhang et al., 2016).  
 
Like all delirium subtypes, hypoactive deliri-
um can occur in a variety of individuals and 
settings. However, hypoactive delirium re-
ceives the least attention and is more difficult 
to recognize (American Psychiatric Associa-
tion, 2013; Bush et al., 2017). Individuals with 
hyperactive or mixed delirium are 50% more 
likely to be identified than those with the hy-
poactive subtype (Bush, Marchington et al. 
2017). Bui et al. (2017) compared delirium 
presence to International Classifications of 
Diseases (ICD) coding finding that only 3% of 
individuals who were delirium positive had a 
diagnosis of delirium due to lack of recogni-
tion or misdiagnosis (Bui et al., 2017).  
 
Delirium triples mortality risk, however, rates 
are considerably higher in the setting of hy-
poactive delirium (Bui et al., 2017). Further 
complicating hypoactive delirium, survivors 
frequently have greater risk for long term 
cognitive impairment (Bush et al., 2017; Lip-
owski, 1983; van den Boogaard, Schoonho-
ven, van der Hoeven, van Achterberg, & 
Pickkers, 2012). A study by Avelino-Silva 
(2018) found 38% of hospitalized patients will 
die within 12 months of hospitalization. Of the 
38% who died, delirium occurred in 47% of 
hospital admissions (Avelina-Silva, 2018). 
When comparing delirium subtype, hypoac-
tive delirium was associated with 33% of the 
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cases and a hazard ratio of 2.43 (95%-1.64-
3.59). The high mortality rates are likely be-
cause only 12% of nurses can definitively 
identify its core features resulting in delayed 
or missed identification (Bui et al., 2017; 
Bush et al., 2017).  
 
While the underlying etiology is not complete-
ly clear, proposed mechanisms include meta-
bolic derangements, inflammation, and neu-
rotransmitter imbalances (van den Boogaard, 
Schoonhoven, Evers, et al., 2012). It is likely 
a combination of the three mechanisms that 
explain the evolution of hypoactive delirium. 
For example, as individuals adapt to over-
whelming physiological stressors, inflamma-
tion ensues and alterations in neurotransmit-
ters (mainly dopamine and acetylcholine) 
lead to behavioral symptoms (Mulkey, Har-
din, Olson, & Munro, 2018). Predisposing 
factors particularly associated with the hypo-
active subtype include advanced age, prior 
cognitive impairment, and medications 
(especially sedatives). As many as 80% of 
older adults experience delirium during hospi-
talization (Mulkey, Hardin, et al., 2018). Of 
those experiencing delirium, the hypoactive 
subtype accounts for 65% (Inouye, Westen-
dorp, & Saczynski, 2014; van Velthuijsen, 
Zwakhalen, Mulder, Verhey, & Kempen, 
2017) When combined predisposing factors 
with risk factors such as higher severity of 
illness, organ failure, metabolic abnormali-
ties, hypoxia and/or anoxia, hypoactive deliri-
um evolves (Hosker & Ward, 2017). One 
study found causes associated with delirium 
were infections at 38%, surgery at 24%, 5% 
were associated with medication use and 3% 
were related to falls. The remaining 30% had 
no established direct cause (van Velthuijsen 
et al., 2017). Another study looking at the 
frequency of delirium in older adults with de-
mentia found as many as 89% of individuals 
with dementia develop delirium in the hospital 
(van Velthuijsen et al., 2017). This article 
seeks to assist nurses in identifying hypoac-
tive delirium by outlining factors that increase 
an individual’s potential for developing hypo-
active delirium. 
 
Advanced Age 
 
          Because of normal physiological 
changes, older adults are more likely to de-
velop hypoactive delirium OR 3.3 (1.9-5.9) 
(Peterson et al., 2006). The aging process 
leads to declines in functional reserve, espe-
cially for those over 70 years of age. As a 
result, risk for hypoactive delirium triples 
(Bilotta, Lauretta, Borozdina, Mizikov, & Ro-
Delirium Subtype Definition /Defining Characteristics 
Delirium An acute fluctuating disturbance in attention, cognition, and level of con-
sciousness 
Hyperactive  Agitation 
 Aggressiveness. 
 Fidgety or restless 
 Speaks quickly and loudly 
Vigilant 
Readily distracted 
Verbal and physical agitation 
Effective communication is difficult 
Hallucinations and delusions  
Hypoactive Motor retardation, 
Apathy 
Slowing of speech, 
Appears to be sedated 
Lethargic and quiet. 
Unusually listless 
Appears depressed 
Lack of motivation  
Withdrawn 
Almost mute 
Extreme stupor 
Mixed Combination of hyperactive and hypoactive delirium 
Table 1. Delirium Subtypes  
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sa, 2013). For example, an age associated 
reduction in acetylcholine reduces the brain’s 
ability to respond to stress (Mulkey, Hardin, 
et al., 2018).  
 
Older adults often have a reduction in pulmo-
nary vital capacity as high as 40% (Lowery, 
Brubaker, Kuhlmann, & Kovacs, 2013). As 
physiologic stress increases, cerebral oxygen 
delivery is diminished; further reducing the 
brain’s ability to compensate. Therefore, 
even mild hypoxia can lead to decreased 
cognitive function (Maldonado, 2008). A mul-
tivariate analysis revealed that individuals 
with the hypoactive and mixed subtypes of 
delirium survived for shorter periods com-
pared to individuals without delirium (hazard 
ratio [HR] =1.65 [95% confidence interval (CI) 
= 1.05–2.59, p = .029] and HR = 2.30 [95% 
CI = 1.44–3.69, p = .001], respectively in a 
cohort of palliative care patients (Kim, Kim, 
Bae, Park, & Kim, 2015).  Therefore, nurses 
should have a heightened suspicion for deliri-
um in older adults with an acute or critical 
illness, especially in the presence of  co-
morbid condition.  
 
Prior Cognitive Impairmen 
 
Prior cognitive impairment, such as demen-
tia, is a significant risk factor for hypoactive 
delirium (Avelino-Silva, Campora, Curiati, & 
Jacob-Filho, 2017; Davis et al., 2015; Perito-
giannis, Bolosi, Lixouriotis, & Rizos, 2015). 
Susceptibility to acute insults increases with 
underlying cognitive or neurodegenerative 
pathology (Davis et al., 2015). Synaptic loss 
related to dementia is a strong correlate of 
cognitive decline and neuronal pathology oc-
curring years before signs of impairment 
(Avelino-Silva et al., 2017). The progressive 
degeneration represents significant brain dis-
connectivity and quantifiable loss of “brain 
reserve,” or ability to compensate (Avelino-
Silva et al., 2017; Numan et al., 2017; Rowe 
et al., 2015).  
 
Although synaptic disconnection is a major 
contributor to delirium, other aspects of de-
mentia, such as activation of the immune 
system and cholinergic dysfunction, are also 
likely contributors (Avelino-Silva et al., 2017; 
Davis et al., 2015; Numan et al., 2017). 
These factors contribute to the overall brain 
function frailty and simply reveal the degener-
ating brain’s inability to compensate during 
times of overwhelming acute stress, such as 
critical illness (Avelino-Silva et al., 2017; Da-
vis et al., 2015). Therefore, while not the 
cause, delirium may unmask an underlying 
neurodegenerative process such as demen-
tia. These underlying neurodegenerative pro-
cesses in turn, increase the susceptibility to 
delirium.  Because prior cognitive impairment 
increases the brain’s vulnerability, nurses 
should closely monitor any patient admitted 
with a history of dementia, brain injury or oth-
er cerebral conditions.  
 
Medications 
 
Factors associated with medication related 
hypoactive delirium include the number of 
medications or polypharmacy (generally > 3), 
the drug’s anticholinergic potential, and the 
use of psychoactive medications (Kruskal-
Wallis test: 17.39, p<0.005) (Horacek, 
Krnacova, Prasko, & Latalova, 2016). The 
number of agents is associated with the phar-
macokinetic and pharmacodynamic effects of 
combining agents (e.g., drug-drug interac-
tions, metabolic inhibitions, and additive neg-
ative effects) (Mulkey, Hardin, et al., 2018). 
Therefore, nurses should suspect the devel-
opment delirium in patients with more than 
three medications such as those with multiple 
co-morbidities or advanced age.  
 
Medications with psychoactive activity (i.e., 
opiates, benzodiazepines and anticholiner-
gics) contribute to as much as 75% of hypo-
active delirium (Horacek et al., 2016; Numan 
et al., 2017). Sedative agents contribute 
through several mechanisms. Sedatives de-
crease the amount of acetylcholine causing 
an acetylcholine deficiency. This deficiency 
results in a disruption of the blood-brain barri-
er’s (BBB) ability to act as a filter, meaning 
the ability to restrict what crosses over from 
central circulation into cerebral circulation is 
impaired, therefore, neuronal damage is en-
hanced. Anticholinergics are also associated 
with a subsequent increase in symptom se-
verity (Maldonado, 2008). Even after adjust-
ing for physical impairment and admission 
diagnosis, anticholinergic drugs can double 
the risk for hypoactive delirium in acutely ill 
older adults.  
 
Among sedatives, GABAergic medications 
(i.e. lorazepam and propofol) are the most 
significant and frequent culprits causing hy-
poactive delirium. Propofol has a higher inci-
dence because it significantly reduces the 
brain's information integration capacity 
(Bilotta et al., 2013). Additionally, lorazepam 
increases the daily risk for delirium transition 
(Maldonado, 2008). Meagher (2011) found 
15/35 or 42% of transitions into the hypoac-
tive subtype were preceded by increased 
benzodiazepine dosing. In turn, benzodiaze-
pine antagonists have been shown to reverse 
coma and improve hypoactive delirium, par-
ticularly in hepatic encephalopathy. Delirium 
has been found to increase length of time 
requiring mechanical ventilation [OR 7.0 (4.7-
10.5)] more frequently than sedative use 
alone [OR 2.9 (1.8-4.6)]. These alterations 
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result in sensory overload and a disruption of 
the circadian rhythm, thereby, interfering with 
physiologic sleep patterns (Numan et al., 
2017). Therefore, polypharmacy, anticholin-
ergics and/or use of psychoactive drugs are 
one of the primary risk factors that quadruple 
the risk for developing hypoactive delirium 
(Rowe et al., 2015). Nurses need to be aware 
of the increased risk for developing delirium 
in patients with receiving sedatives, psycho-
actives or any anticholinergic medications. 
 
Critical Illness 
 
Illness, trauma, and surgical procedures offer 
several triggering factors: anesthetic use, 
extensive tissue trauma, blood loss and ane-
mia, blood transfusions, hypoxia, and initiat-
ing the inflammatory process (Horacek et al., 
2016). van den Boogaard (2012) found hypo-
active delirium increased ICU length of stay 
(LOS) from 1-5 days to 2-9 days and hospital 
LOS from 1-5 days to 8-32 days. The severity 
of the initial injury or underlying medical con-
dition, mechanical ventilation and high Acute 
Physiologic Assessment and Chronic Health 
Evaluation (APACHE) scores are significantly 
directly correlated with hypoactive delirium 
(Adamis, Meagher, Rooney, Mulligan, & 
McCarthy, 2017). 
 
In a recent meta-analysis, mortality rates 
were significantly higher in individuals with 
reduced levels of consciousness admitted 
with respiratory conditions (38%).  Respirato-
ry conditions were found to increase the odds 
of developing delirium (OR 3.35 [2.59, 4.33] 
higher than cardiac at 5.4% (OR 10.00 [3.6, 
27.76], endocrine at 2.5% (OR 25.6 [4.05, 
161.73]) or gastrointestinal at 5.9% with odds 
ratios of 11.26 [4.34, 29.25] conditions (Todd 
et al., 2017).  The more intense the insult, the 
more pronounced the response.  
 
The combination of an intense insult such as 
an acute infection or trauma, and the associ-
ated systemic inflammatory response result 
in high levels of stress capable of altering 
BBB permeability. This leads to the initiation 
of a cerebral inflammatory response and re-
lease of cerebral cytokines (Kozak et al., 
2017). As a result, there are shifts in extra-
vascular fluid with potential to develop peri-
vascular edema. With the formation of ede-
ma, there is a significant risk for diffuse mi-
crocirculatory impairment along with de-
creased perfusion and longer oxygen diffu-
sion distances (Kozak et al., 2017).  
 
Cerebral and systemic leukocyte activation 
(immune response) result in release of free 
oxygen radicals and enzymes exacerbating 
the systemic inflammatory response and fur-
ther contributing to the evolution of hypoac-
tive delirium (Bergeron, Dubois, Dumont, Di-
al, & Skrobik, 2001; Nguyen et al., 2014; van 
den Boogaard, Schoonhoven, Evers, et al., 
2012). Therefore, delirium may represent a 
central nervous system manifestation of a 
systemic disease state that has crossed the 
BBB. Because critical illness increases physi-
ologic stress on the brain, patients in critical 
care units are particularly vulnerable and 
should be routinely monitored for an appro-
priate standardized delirium screening tool 
(Mulkey, Roberson, Everhart, & Hardin, 
2018). 
 
Organ Failure and Metabolic Abnormali-
ties 
 
Abnormal laboratory values can significantly 
increase the risk of hypoactive delirium in all 
populations OR 3.4 (1.3-8.7) (Bilotta et al., 
2013; Horacek et al., 2016; Inouye et al., 
2014). Alterations in sodium (sodium <130 or 
>150 mEq/L) and potassium (<3.0 or >6.0 
mEq/L) levels (Pearson’s r=0.2189, P< 0.05), 
as well as other electrolyte, can lead to the 
mental status changes associated with deliri-
um. While not clearly understood, sodium 
imbalances lead to cellular swelling, thereby 
impairing oxygen delivery (Maldonado, 
2008). In the elderly, electrolyte abnormali-
ties, especially hyponatremia, often caused 
by renal disease and chronic diuretic therapy 
should be promptly corrected (Bilotta et al., 
2013). Patients with an increased risk elec-
trolyte abnormalities such as those with renal 
impairment, diabetes, cirrhosis or the pres-
ence of electrolyte imbalances should be 
closely observed for signs and symptoms of 
delirium.  
 
Dehydration, fluid deficits, prolonged fasting 
time (> 6 hours), and low serum albumin con-
centrations contribute because of hypoperfu-
sion, both cerebral and renal (Horacek et al., 
2016). This is thought to be due to increased 
drug and metabolite concentrations and de-
creased renal elimination of drugs, metabo-
lites, and toxic by-products. Failure to correct 
hypoglycemia (<60 mg/dL), hyperglycemia 
(>300 mg/dL), and anemia (Hb <120g/L) are 
risk factors due to the effects on brain metab-
olism and oxygen transport. For example, 
Horace (2016) found low Hb levels (<120g/L) 
increased delirium duration by 11 hours. 
These alterations induce drug and hormone 
binding activity along with antioxidant and 
oxygen radical trapping and are correlated 
with cognitive impairment. Because of the 
associated impairment in cognitive perfor-
mance these abnormalities are considered 
precipitating factors (Horacek et al., 2016).  
 
Therefore, nurses should be suspicious for 
delirium in patients who have an increased 
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risk for dehydration or anemia such as post-
operative patients and those with acute 
bleeding.  
 
Hypoxia and Anoxia 
 
Hypoxia and global mild ischemic illness inju-
ry often co-exist with critical illness, increas-
ing oxidative failure. This correlates with a 
17% increased risk for developing hypoactive 
as well as delirium progression (Bilotta et al., 
2013; Maldonado, 2008; Stransky et al., 
2011). Low hemoglobin, hematocrit, and 
pulse oximetry occur approximately 48 hours 
before the onset of oxidative stress with alter-
ations being more severe in individuals expe-
riencing hypoactive delirium (Maldonado, 
2008; Stransky et al., 2011). Severe illness, 
combined with decreased oxygen supply 
and/or increased oxygen demand leads to 
decreased cerebral oxygen availability 
(Maldonado, 2008). Inadequate oxygenation 
leads to abnormal neurotransmitter function, 
ineffective elimination of neurotoxic by-
products, and alterations in electrolytes 
(Numan et al., 2017).  
 
Rapid depletion of energy stores from cere-
bral ischemia result in cell death. These 
changes then result in reconfiguration of neu-
ronal networks. For example, sepsis causes 
an oxygen supply and demand imbalance 
due to lower hemoglobin level, cerebral blood 
flow, and cerebral oxygen delivery 
(Nedergaard, Jensen, Stylsvig, Lauridsen, & 
Toft, 2016). In critically ill delirious patients, 
reduced cerebral blood flow and the associat-
ed imbalances increase the chronic hypoxic 
injury. Patients admitted with an acute respir-
atory distress or failure and those with a his-
tory of respiratory conditions such as asthma 
and COPD are at increased risk.  
 
Identification and Assessment 
 
           Using a standardized assessment tool 
for sedation and agitation can assist with 
identifying patients who may be developing 
hypoactive and hyperactive delirium symp-
toms (Mulkey, Roberson, et al., 2018). Like-
wise, use of these assessment screening 
tools can differentiate delirium subtypes in 
patients identified. The Richmond Agitation 
Sedation Scale (RASS) is a component of 
the Confusion Assessment Method- Intensive 
Care Unit (CAM-ICU). Scoring is based on 
the individual’s activity with -5 being nonre-
sponsive to +4 being agitated and combative. 
Individuals with a RASS of -2 to +4 are con-
sidered appropriate for delirium assessment 
with the CAM-ICU. If the CAM-ICU is positive 
for delirium, the RASS score can also be 
used to indicate a delirium subtype. Individu-
als with a lower score (0 to -3) are consid-
ered hypoactive while a higher score (+1 to 
+4) indicates hyperactive delirium (Michaud, 
Bullard, Harris, & Thomas, 2015; Peterson et 
al., 2006).  
 
 
Table 2. Implications for Practice 
 
Hypoactive delirium is difficult to detect  
Understanding clinical features and risk factors is critical for detection 
Standardized assessment tools appropriate for the population should be used  
Frequent assessments are needed because delirium fluctuates 
Prevention and intervention strategies should be implemented early 
Regularly assess medication for delirium risk and response  
Strongly consider continuation of home medications,  
Promote adequate pain management and reduction of sedation to the minimum dose required  
Early mobility, limiting restraint, adequate hydration and nutrition are key to prevention and treat-
ment 
Timing of care should promote periods of uninterrupted rest and sleep (i.e. giving up middle of the 
night bathing, timing of medication administration and routine lab/x-rays) 
Establishing day and night routines will reduce risk and help resolve delirium  
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Nursing Implications 
 
Nurses are the cornerstone to prevention and 
identification of hypoactive delirium and pre-
venting the associated negative sequela. Be-
cause hypoactive delirium is more difficult to 
detect, nurses need to ensure they under-
stand the clinical features and risk factors. 
For early accurate detection nurses should 
frequently assess individuals using an appro-
priate standardized tool. Maintaining con-
sistency and accuracy of assessments has 
been identified as a significant challenge to 
obtaining ongoing accurate assessments. 
(See Table 2) Understanding factors that in-
crease an individual’s risk for developing de-
lirium will assist with identification, and selec-
tion of prevention and intervention strategies 
specific to the individual. Because medica-
tions can have a significant impact on deliri-
um risk, medications and patient response 
should be reviewed on an ongoing basis. Se-
rious consideration should be directed toward 
continuation of home medications, adequate 
pain management and reducing sedation to 
the minimum dose required.  
 
Early mobility, limiting use of restraints, ade-
quate hydration, and limiting interruptions to 
maintaining adequate nutrition are key to pre-
vention and treatment of delirium. Finally, 
timing of care is also extremely important. 
Promoting quiet time consistent with circadi-
an rhythms (2-4 am & 2-4 pm), uninterrupted 
sleep, establishing day and night routines 
and timing of care (i.e. giving up middle of the 
night bathing, timing of medication admin-
istration and routine lab/x-rays) will reduce 
risk and help resolve delirium. To assist in 
remembering key components of nursing 
care vital to delirium management, the follow-
ing acronym Q-U-I-E-T has been provided. 
(See Table 3)  
 
 
Conclusion 
 
 Often unrecognized and underappreci-
ated, hypoactive delirium or “quiet delirium” is 
more difficult to detect, therefore, frequently 
associated with delays in delirium treatment 
and increased mortality (up to 58%) (Todd et 
al., 2017). Advanced age and prior cognitive 
impairment are predisposing factors due to a 
reduced ability to compensate for neuro-
chemical changes. Medications with anticho-
linergic or sedative effects and severe illness 
result in higher levels of stress. While there 
are many causes for hypoactive delirium, 
combining risk factors, as seen in critical ill-
ness, magnifies these risks. Understanding 
the risk factors will allow nurses to identify 
the presence of hypoactive delirium. Identifi-
cation through ongoing assessment for deliri-
um is of the utmost importance (Peritogiannis 
et al., 2015).  
 
Reflective Questions 
 
How is hypoactive delirium different from oth-
er delirium subtypes, and why is it important? 
 
Of the individuals I care for, who is at great-
est risk for developing hypoactive delirium? 
 
What interventions might be appropriate for 
the prevention of hypoactive delirium? 
 
Do I currently provide care that promotes the 
prevention of delirium? 
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